Syngene International Limited

NSE:SYNGENE.NS

898.45 (INR) • At close November 8, 2024
Bedrijfsnaam Syngene International Limited
Symbool SYNGENE.NS
Munteenheid INR
Prijs 898.45
Beurswaarde 360,541,968,080
Dividendpercentage 0.11%
52-weken bereik 607.65 - 945.25
Industrie Biotechnology
Sector Healthcare
CEO Mr. Jonathan Brittan Hunt
Website https://www.syngeneintl.com

An error occurred while fetching data.

Over Syngene International Limited

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology

Vergelijkbare Aandelen

Pfizer Limited logo

Pfizer Limited

PFIZER.NS

5,286.85 INR

Ipca Laboratories Limited logo

Ipca Laboratories Limited

IPCALAB.NS

1,558.65 INR

Fortis Healthcare Limited logo

Fortis Healthcare Limited

FORTIS.NS

620.75 INR

GlaxoSmithKline Pharmaceuticals Limited logo

GlaxoSmithKline Pharmaceuticals Limited

GLAXO.NS

2,561.15 INR

Lupin Limited logo

Lupin Limited

LUPIN.NS

2,104.6 INR

Dr. Lal PathLabs Limited logo

Dr. Lal PathLabs Limited

LALPATHLAB.NS

3,060.2 INR

Sanofi India Limited logo

Sanofi India Limited

SANOFI.NS

6,451.9 INR

Ajanta Pharma Limited logo

Ajanta Pharma Limited

AJANTPHARM.NS

2,864.2 INR

Alembic Pharmaceuticals Limited logo

Alembic Pharmaceuticals Limited

APLLTD.NS

1,038.2 INR

Narayana Hrudayalaya Limited logo

Narayana Hrudayalaya Limited

NH.NS

1,290.95 INR

Financiële Gegevens

Cijfers zijn in miljoenen (INR)

Cijfers zijn in miljoenen (INR)